Toffee Full Face and Toffee Nasal Mask Evaluation in Obesity Hypoventilation Syndrome (NZ)
NCT02486380 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4
Last updated 2022-06-24
Summary
This investigation is to evaluate the performance, comfort and ease of use of the Toffee full face and toffee nasal mask masks amongst Obesity Hypoventilation Syndrome (OHS) patients in an overnight study.
Conditions
- Obesity Hypoventilation Syndrome
Interventions
- DEVICE
-
Toffee full face mask/toffee nasal mask
Toffee full face mask/toffee nasal mask
Sponsors & Collaborators
-
Fisher and Paykel Healthcare
lead INDUSTRY
Principal Investigators
-
Bhavi Ogra, BSc · Fisher & Paykel Healthcare
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-07-31
- Primary Completion
- 2017-03-31
- Completion
- 2017-03-31
Countries
- New Zealand
Study Locations
More Related Trials
-
COmmunity Patients at Risk of Viral Infections Including SARS-CoV-2
NCT04858451 ·Status: TERMINATED ·Phase: PHASE2
-
Cardiac Effects of Spiolto®/Respimat® in Patients With Congestive Heart Failure and COPD
NCT02812862 ·Status: WITHDRAWN ·Phase: PHASE4
-
Study to Evaluate the Effect of GBT440 Administered to Subjects With IPF on Supplemental Oxygen at Rest
NCT02989168 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Investigate the Safety Tolerability Pharmacokinetics, and Pharmacodynamics of Inhaled and Intravenous GSK2862277 in Healthy Volunteers
NCT01818024 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 1/Phase 2a Study of AERO-007 Inhalation Solution, a Nebulized LABA/LAMA Combination for Maintenance Treatment of COPD
NCT06841640 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Hyperbaric Oxygen Therapy in Non-ventilated COVID-19 Patients
NCT04409886 ·Status: TERMINATED ·Phase: PHASE4
-
Study of Biomarkers of Airway Inflammation (0000-128)
NCT00869596 ·Status: COMPLETED ·Phase: PHASE1
-
Study of the Effect of FLUTTER® VRP1 (PEP and Oscillating High Frequency).
NCT01209546 ·Status: TERMINATED ·Phase: PHASE1
-
The Safety, Tolerability, PK and PD of GSK2586881 in Patients With Acute Lung Injury
NCT01597635 ·Status: COMPLETED ·Phase: PHASE2
-
Non Inferiority Trial for Detection of nCOVID-19 Through Analysis of Exhaled Breath Aerosols
NCT04467112 ·Status: COMPLETED
-
A Study of Safety & Blood Levels of IDL-2965 in Healthy Subjects and Patients With a Special Type of Pulmonary Fibrosis
NCT03949530 ·Status: TERMINATED ·Phase: PHASE1
-
Long-term Use of Spiolto Respimat in Japanese Patients With Chronic Obstructive Pulmonary Disease
NCT02850978 ·Status: COMPLETED
-
Safety, Tolerability and Efficacy of S-1226 in Cystic Fibrosis and Non CF Bronchiectasis
NCT03903913 ·Status: UNKNOWN ·Phase: PHASE2
-
Comparison of Viral Particle Dispersion Following Administration of an MDI or Nebulizer in Subjects With COVID-19
NCT04681079 ·Status: COMPLETED
-
Study to Assess CSL787 in Non-cystic Fibrosis Bronchiectasis (NCFB)
NCT04643587 ·Status: COMPLETED ·Phase: PHASE1
-
Dose Range Finding, Efficacy, and Safety Study of Nebulized CSL787 in Adults With Non-cystic Fibrosis Bronchiectasis (NCFB)
NCT07048262 ·Status: RECRUITING ·Phase: PHASE2
-
JUNIPER: A Phase 2 Study to Evaluate the Safety, Biological Activity, and PK of ND-L02-s0201 in Subjects With IPF
NCT03538301 ·Status: COMPLETED ·Phase: PHASE2
-
Sputum Clearance Effects of Hypertonic Saline in Non-cystic Fibrosis Bronchiectasis
NCT02392663 ·Status: COMPLETED ·Phase: NA
-
A Comprehensive Evaluation of the Impact of ATP on Laryngeal Symptoms, Hypersensitivity and Function
NCT05570981 ·Status: UNKNOWN
-
Safety and Feasibility Study of Rejuvenair™ for Treating Chronic Bronchitis Patients
NCT02483637 ·Status: COMPLETED ·Phase: NA
-
Comparison Between Different Ways for Using Lidocaine During FB
NCT06563050 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
TruFreeze™ Airway Obstruction: TAO STUDY
NCT01903850 ·Status: WITHDRAWN ·Phase: PHASE4
-
Safety and Efficacy of Adipose Derived Stem Cells for Chronic Obstructive Pulmonary Disease
NCT01559051 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Comparison of Time to Extubation Using Sugammadex or Neostigmine
NCT04606901 ·Status: COMPLETED ·Phase: PHASE4
-
Inspiratory Flow and Volumes in Bronchiectatics
NCT00656565 ·Status: COMPLETED